Shubulade Smith

Last updated

Shubulade Smith CBE is a British academic and consultant psychiatrist at the South London and Maudsley NHS Foundation Trust (SLaM). She is a senior lecturer at King's College, London and Clinical Director at the NCCMH (National Collaborating Centre for Mental Health) and forensic services at SLaM, [1] [2] [3] [4] and is currently serving as the first black President of the Royal College of Psychiatrists .

Contents

Early life and education

Smith grew up in Manchester. Her close contact with a wide range of families of different class and stature led her to try and better understand human interaction, including violence, physical problems in mental illness, and the effects of antipsychotic drugs. [5] [6] She graduated from St Thomas Aquinas High School, Manchester, and entered Guy's Hospital Medical School in 1985, earning her Bachelor of Medicine, Bachelor of Surgery (MBBS) in 1991. [7]

Career

Smith joined the South London and Maudsley NHS Foundation Trust in September 1999 as a consultant psychiatrist. [7] In July 2004 she also became a clinical senior lecturer at the Institute of Psychiatry. [7] In 2017, Smith became Clinical Director for the NCCMH, a collaboration between the Royal College of Psychiatrists and University College London that works to improve mental health services and rectify inequalities in mental health. [8] In February 2020, Smith then also became Clinical Director for forensic services at SLaM.

Currently,[ as of? ] Smith is also the Clinical and Strategic Director of the National Collaborating Centre for Mental Health (NCCMH). In this role, she has designed and developed services to improve the quality of patient care, including The Community Mental Health Framework for Adults and Older Adults [9] and The Advancing Mental Health Equality Resource [10]

On 19 January 2023, she was elected the first black President of the Royal College of Psychiatrists, winning 54.1% of the vote. [11] She began serving on 11 July 2023. [12]

Research

Smith has always focused on academics, including research into the hormonal and reproductive effects of antipsychotic medications, the effect of vitamin D in reducing psychosis, and in particular, the mental health issues of those in minority ethnic groups. [5] Recently, Smith published a paper highlighting how almost half the explanations given for higher rates of detention in Black people are unsupported by evidence and are based on cultural stereotypes and assumptions. She says, "Future research should avoid cultural stereotypes and assumptions, and amalgamation of ethnic groups should be discouraged to better inform policy and practice." [13] Smith has campaigned for a better understanding of mental health issues, and has raised awareness about racism in healthcare. Smith believed this why there are generally a higher proportion of black people detained under the mental health service, but added "psychiatry is not where the problem starts". [14] Smith's research into the short term management of violent behaviour and reducing forced injection during restraint has been adopted as part of national guidance and now forms part of the recommendations for Rapid Tranquillisation in the recent NaPICU/BAP guidelines. [15]

In 2015, she led an inquest into the suicide of a woman in Pembrokeshire three years earlier, saying that a better understanding of mental health issues may have prevented this. [16] She has said that "most people with psychosis are not violent" and other factors from growing up make them violent, as she saw with classmates. Smith would like "a bigger sociopolitical response" to the problems and concerns with mental health, how it affects families, and how important it is to treat any issues early. [5] She is concerned that people with severe mental illness (SMI) will die around 15 to 20 years earlier than the general population. [17]

Smith also campaigns for better resourcing of mental health services, noting that austerity measures have likely been associated with increases in mental health crises and involuntary admissions. [18] Smith has also been involved in modernising the Mental Health Act. The recommendations in the report "Reasons behind the rising rate of admissions under the Mental Health Act" have been reviewed by the central government and the recommendations of the MHARAC (Mental Health of African and Caribbean) group have been adopted by the Cabinet Office. The Mental Health Act White Paper is currently in preparation based on the recommendations of the Independent Review, of which Smith was the deputy chair. [19]

Selected publications

Related Research Articles

<span class="mw-page-title-main">Clozapine</span> Atypical antipsychotic medication

Clozapine is a psychiatric medication and is the first atypical antipsychotic to be discovered. It is primarily used to treat people with schizophrenia and schizoaffective disorder who have had an inadequate response to two other antipsychotics or who have been unable to tolerate other drugs due to extrapyramidal side effects. It is also used for the treatment of psychosis in Parkinson's disease. Clozapine is regarded as the gold-standard treatment when most other medications are ineffective and its use is recommended by multiple international treatment guidelines, after resistance to two other antipsychotic medications.

<span class="mw-page-title-main">Akathisia</span> Movement disorder involving a feeling of inner restlessness

Akathisia is a movement disorder characterized by a subjective feeling of inner restlessness accompanied by mental distress and an inability to sit still. Usually, the legs are most prominently affected. Those affected may fidget, rock back and forth, or pace, while some may just have an uneasy feeling in their body. The most severe cases may result in aggression, violence, and/or suicidal thoughts. Akathisia is also associated with threatening behaviour and physical aggression that is greatest in patients with mild akathisia, and diminishing with increasing severity of akathisia.

Biological psychiatry or biopsychiatry is an approach to psychiatry that aims to understand mental disorder in terms of the biological function of the nervous system. It is interdisciplinary in its approach and draws on sciences such as neuroscience, psychopharmacology, biochemistry, genetics, epigenetics and physiology to investigate the biological bases of behavior and psychopathology. Biopsychiatry is the branch of medicine which deals with the study of the biological function of the nervous system in mental disorders.

<span class="mw-page-title-main">Institute of Psychiatry, Psychology and Neuroscience</span> Research institution in London, England

The Institute of Psychiatry, Psychology and Neuroscience (IoPPN) is a research institution dedicated to discovering what causes mental illness and diseases of the brain. In addition, its aim is to help identify new treatments for them and ways to prevent them in the first place. The IoPPN is a faculty of King's College London, England, previously known as the Institute of Psychiatry (IoP).

People with schizophrenia are at a higher than average risk of physical ill health, and earlier death than the general population. The fatal conditions include cardiovascular, respiratory and metabolic disorders.

Child and adolescent psychiatry is a branch of psychiatry that focuses on the diagnosis, treatment, and prevention of mental disorders in children, adolescents, and their families. It investigates the biopsychosocial factors that influence the development and course of psychiatric disorders and treatment responses to various interventions. Child and adolescent psychiatrists primarily use psychotherapy and/or medication to treat mental disorders in the pediatric population.

A psychiatric assessment, or psychological screening, is the process of gathering information about a person within a psychiatric service, with the purpose of making a diagnosis. The assessment is usually the first stage of a treatment process, but psychiatric assessments may also be used for various legal purposes. The assessment includes social and biographical information, direct observations, and data from specific psychological tests. It is typically carried out by a psychiatrist, but it can be a multi-disciplinary process involving nurses, psychologists, occupational therapist, social workers, and licensed professional counselors.

Early intervention in psychosis is a clinical approach to those experiencing symptoms of psychosis for the first time. It forms part of a new prevention paradigm for psychiatry and is leading to reform of mental health services, especially in the United Kingdom and Australia.

Psychiatric Intensive Care Units or PICUs are specialist twenty-four hour inpatient wards that provide intensive assessment and comprehensive treatment to individuals during the most acute phase of a serious mental illness.

Psychiatric intensive care is for patients who are in an acutely disturbed phase of a serious mental disorder. There is an associated loss of capacity for self-control with a corresponding increase in risk which does not allow their safe, therapeutic management and treatment in a less acute or a less secure mental health ward. Care and treatment must be patient-centred, multidisciplinary, intensive and have an immediacy of response to critical clinical and risk situations. Patients should be detained compulsorily under the appropriate mental health legislative framework, and the clinical and risk profile of the patient usually requires an associated level of security. Psychiatric intensive care is delivered by qualified and suitably trained multidisciplinary clinicians according to an agreed philosophy of unit operational policy underpinned by the principles of therapeutic intervention and dynamic clinically focused risk management

The Critical Psychiatry Network (CPN) is a psychiatric organization based in the United Kingdom. It was created by a group of British psychiatrists who met in Bradford, England in January 1999 in response to proposals by the British government to amend the Mental Health Act 1983. They expressed concern about the implications of the proposed changes for human rights and the civil liberties of people with mental health illness. Most people associated with the group are practicing consultant psychiatrists in the United Kingdom's National Health Service (NHS), among them Dr Joanna Moncrieff. A number of non-consultant grade and trainee psychiatrists are also involved in the network.

Pamela Jane Taylor, is a British psychiatrist and academic, who specialises in the links between psychosis and violence, and mental and physical health in the criminal justice system. Since 2004, she has been Professor of Forensic Psychiatry in the Department Institute of Psychological Medicine and Clinical Neurosciences of Cardiff University.

<span class="mw-page-title-main">National Collaborating Centre for Mental Health</span>

The National Collaborating Centre for Mental Health (NCCMH) is a collaboration between the Royal College of Psychiatrists and the Centre for Outcomes Research and Effectiveness at University College London (UCL). The NCCMH aims to promote the role of evidence synthesis in making informed judgments about healthcare policy. The NCCMH has a history of developing guidelines, conducting systematic reviews and developing implementation guidance for commissioners and service providers. Formed in 2001, on 1 April 2016 a new guideline development centre, the National Guideline Alliance, based at the Royal College of Obstetricians and Gynaecologists took over the clinical guideline programme that had been run by NCCMH.

<span class="mw-page-title-main">National Psychosis Unit</span> Hospital in England

The National Psychosis Unit is a national treatment centre for patients with schizophrenia and other psychotic disorders, in the United Kingdom. The unit is a tertiary referral centre in the National Health Service. It is located at the Bethlem Royal Hospital, part of the South London and Maudsley NHS Foundation Trust. It is closely affiliated to the Institute of Psychiatry, King's College London, and forms part of the Psychosis Clinical Academic Group of King's Health Partners.

The following outline is provided as an overview of and topical guide to psychiatry:

Joanna Moncrieff is a British psychiatrist and academic. She is Professor of Critical and Social Psychiatry at University College London and a leading figure in the Critical Psychiatry Network. She is a prominent critic of the modern 'psychopharmacological' model of mental disorder and drug treatment, and the role of the pharmaceutical industry. She has written papers, books and blogs on the use and over-use of drug treatment for mental health problems, the mechanism of action of psychiatric drugs, their subjective and psychoactive effects, the history of drug treatment, and the evidence for its benefits and harms. She also writes on the history and politics of psychiatry more generally. Her best known books are The Myth of the Chemical Cure and The Bitterest Pills.

<span class="mw-page-title-main">Federal Neuro-Psychiatric Hospital, Yaba</span> Hospital in Lagos State, Nigeria

The Federal Neuro Psychiatric Hospital, also known as Yaba Psychiatric Hospital or Yaba Left, is a Nigerian Federal psychiatric hospital in Yaba, a suburb of Lagos.

<span class="mw-page-title-main">Tamsin Ford</span> British psychiatrist

Tamsin Jane FordCBE, FRCPsych, FMedSci is a British psychiatrist specialising in children's mental health. Since 2019 she has been based at the University of Cambridge where she is now Professor of Child and Adolescent Psychiatry, Head of the Department of Psychiatry and Fellow of Hughes Hall. She has been heavily involved with the Incredible Years Teacher Classroom Management (TCM) programme, created by Carolyn Webster-Stratton, which aims to raise and improve children's mental health in primary schools across Devon. Her work also ties in with the Strengths and Difficulties Questionnaire (SDQ), created by UK psychiatrist, Robert Goodman.

Wendy Katherine Burn is a Consultant in Old Age Psychiatry. She was President of the Royal College of Psychiatrists from 2017 to 2020.

<span class="mw-page-title-main">David Taylor (professor)</span>

David Taylor FFRPS FRPharmS is a British professor. He is the head of the Pharmaceutical Sciences Clinical Academic Group within King's Health Partners. Taylor has been lead author and editor of the Maudsley Prescribing Guidelines in Psychiatry since 1994. In 2014, Taylor was named as one of the top 100 clinical leaders in the UK National Health Service.

References

  1. ↑ "croydon and bdp management structure" (PDF). slam.nhs.uk. SLaM. Retrieved 23 June 2020.
  2. ↑ "Shubulade Smith". King's College, London. Retrieved 13 February 2019.
  3. ↑ "Shubulade Smith". Sloane Court Clinic. Retrieved 13 February 2019.
  4. ↑ "Dr Shubulade Smith awarded Psychiatrist of the Year". slam.nhs.uk. SLAM NHS. Retrieved 22 June 2020.
  5. 1 2 3 Kirby, Tony (August 2016). "Shubulade Smith: seeing the bigger picture". The Lancet Psychiatry. 3 (8): 711. doi:10.1016/S2215-0366(16)30133-X. PMID   27475766 . Retrieved 13 February 2019.
  6. ↑ Smith, Shubulade; O'Keane, Veronica; Murray, Robin (2002). "Sexual dysfunction in patients taking conventional antipsychotic medication". British Journal of Psychiatry . 181: 49–55. doi: 10.1192/bjp.181.1.49 . PMID   12091263.
  7. 1 2 3 "Shubulade Smith". LinkedIn . 2019. Retrieved 14 February 2019.
  8. ↑ "About the NCCMH". rcpsych.ac.uk. Royal College of Psychiatrists. Retrieved 22 June 2020.
  9. ↑ "The Community Mental Health Framework for Adults and Older Adults | Royal College of Psychiatrists". RC PSYCH ROYAL COLLEGE OF PSYCHIATRISTS. Retrieved 13 September 2022.
  10. ↑ "Advancing Mental Health Equality | Royal College of Psychiatrists". RC PSYCH ROYAL COLLEGE OF PSYCHIATRISTS. Retrieved 13 September 2022.
  11. ↑ "Dr Lade Smith CBE elected as the next President of the Royal College of Psychiatrists". King's College London. 19 January 2023. Retrieved 12 July 2023.
  12. ↑ "Goodbye and thank you Adrian, welcome Lade!". The Royal College of Psychiatrists. 12 July 2023. Retrieved 12 July 2023.
  13. ↑ Barnett, Phoebe; MacKay, Euan; Matthews, Hannah; Gate, Rebecca; Greenwood, Helen; Ariyo, Kevin; Bhui, Kamaldeep; Halvorsrud, Kristoffer; Pilling, Stephen; Smith, Shubulade (4 March 2019). "Ethnic variations in compulsory detention under the Mental Health Act: a systematic review and meta-analysis of international data". The Lancet. 6 (4): 305–317. doi:10.1016/S2215-0366(19)30027-6. PMC   6494977 . PMID   30846354.
  14. ↑ "Race row in mental health service". BBC Newsnight. 21 May 2007. Retrieved 13 February 2019.
  15. ↑ "NEW! Joint BAP NAPICU evidence based guidelines for the clinical management of acute disturbance (de-escalation and rapid tranquillisation)". napicu.org.uk. napicu. May 2018. Retrieved 22 June 2020.
  16. ↑ "Grieving mother's suicide due to 'personality disorder'". BBC News. 20 February 2015. Retrieved 13 February 2019.
  17. ↑ "Dr Shubulade Smith Speaks on the impact of psychotropic medications on the physical health of those with serious mental health conditions". Health Care Conferences. Retrieved 14 February 2019.
  18. ↑ Smith, Shubulade; Gate, Rebecca; Ariyo, Kevin; Saunders, Rob; Taylor, Clare; Bhui, Kamaldeep; Mavranezouli, Ifigeneia; Heslin, Margaret; Greenwood, Helen; Matthews, Hannah; Barnett, Phoebe; Pilling, Stephen (13 December 2019). "Reasons behind the rising rate of involuntary admissions under the Mental Health Act (1983): Service use and cost impact". International Journal of Law and Psychiatry. 68: 101506. doi: 10.1016/j.ijlp.2019.101506 . PMID   32033706.
  19. ↑ "Modernising the Mental Health Act – final report from the independent review". www.gov.uk. Department of Health and Social Care. Retrieved 22 June 2020.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.